GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » EV-to-EBIT

Cessatech AS (XSAT:CESSA) EV-to-EBIT : -4.19 (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cessatech AS's Enterprise Value is kr87.77 Mil. Cessatech AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-20.93 Mil. Therefore, Cessatech AS's EV-to-EBIT for today is -4.19.

The historical rank and industry rank for Cessatech AS's EV-to-EBIT or its related term are showing as below:

XSAT:CESSA' s EV-to-EBIT Range Over the Past 10 Years
Min: -5.48   Med: 0   Max: 0.4
Current: -3.9

During the past 4 years, the highest EV-to-EBIT of Cessatech AS was 0.40. The lowest was -5.48. And the median was 0.00.

XSAT:CESSA's EV-to-EBIT is ranked worse than
100% of 423 companies
in the Biotechnology industry
Industry Median: 10.05 vs XSAT:CESSA: -3.90

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cessatech AS's Enterprise Value for the quarter that ended in Mar. 2024 was kr82.92 Mil. Cessatech AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-20.93 Mil. Cessatech AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -25.24%.


Cessatech AS EV-to-EBIT Historical Data

The historical data trend for Cessatech AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS EV-to-EBIT Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- -7.20 0.07 -4.30

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -0.63 -2.23 -4.30 -

Competitive Comparison of Cessatech AS's EV-to-EBIT

For the Biotechnology subindustry, Cessatech AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cessatech AS's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cessatech AS's EV-to-EBIT falls into.



Cessatech AS EV-to-EBIT Calculation

Cessatech AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=87.768/-20.928
=-4.19

Cessatech AS's current Enterprise Value is kr87.77 Mil.
Cessatech AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS  (XSAT:CESSA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cessatech AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-20.928/82.9177
=-25.24 %

Cessatech AS's Enterprise Value for the quarter that ended in Mar. 2024 was kr82.92 Mil.
Cessatech AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cessatech AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cessatech AS (XSAT:CESSA) Business Description

Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS (XSAT:CESSA) Headlines

No Headlines